Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 110

1.

Preoperative prediction of type 2 diabetes remission after Roux-en-Y gastric bypass surgery: a retrospective cohort study.

Still CD, Wood GC, Benotti P, Petrick AT, Gabrielsen J, Strodel WE, Ibele A, Seiler J, Irving BA, Celaya MP, Blackstone R, Gerhard GS, Argyropoulos G.

Lancet Diabetes Endocrinol. 2014 Jan;2(1):38-45.

2.

Type 2 diabetes after gastric bypass: remission in five models using HbA1c, fasting blood glucose, and medication status.

Blackstone R, Bunt JC, Cortés MC, Sugerman HJ.

Surg Obes Relat Dis. 2012 Sep-Oct;8(5):548-55. doi: 10.1016/j.soard.2012.05.005. Epub 2012 May 18.

PMID:
22721581
3.

Type 2 diabetes remission following gastric bypass: does diarem stand the test of time?

Mehaffey JH, Mullen MG, Mehaffey RL, Turrentine FE, Malin SK, Kirby JL, Schirmer B, Hallowell PT.

Surg Endosc. 2016 May 13. [Epub ahead of print]

PMID:
27177952
4.

Preoperative fasting plasma C-peptide level may help to predict diabetes outcome after gastric bypass surgery.

Aarts EO, Janssen J, Janssen IM, Berends FJ, Telting D, de Boer H.

Obes Surg. 2013 Jul;23(7):867-73. doi: 10.1007/s11695-013-0872-8.

PMID:
23475775
5.

Remission of type 2 diabetes after Roux-en-Y gastric bypass is associated with greater weight loss.

Kadera BE, Lum K, Grant J, Pryor AD, Portenier DD, DeMaria EJ.

Surg Obes Relat Dis. 2009 May-Jun;5(3):305-9. doi: 10.1016/j.soard.2009.02.007. Epub 2009 Feb 26.

PMID:
19460674
6.

EXTERNAL VALIDATION OF THE DIAREM SCORE AS REMISSION PREDICTOR OF DIABETES MELLITUS TYPE 2 IN OBESE PATIENTS UNDERGOING ROUX-EN-Y GASTRIC BYPASS.

Sampaio-Neto J, Nassif LS, Branco-Filho AJ, Bolfarini LA, Loro LS, de Souza MP, Bianco T.

Arq Bras Cir Dig. 2015;28 Suppl 1:19-22. doi: 10.1590/S0102-6720201500S100007. English, Portuguese.

7.

Preoperative use of incretins is associated with increased diabetes remission after RYGB surgery among patients taking insulin: a retrospective cohort analysis.

Wood GC, Gerhard GS, Benotti P, Petrick AT, Gabrielsen JD, Strodel WE, Ibele A, Rolston DD, Still CD, Argyropoulos G.

Ann Surg. 2015 Jan;261(1):125-8. doi: 10.1097/SLA.0000000000000588.

8.

Predictors of short-term diabetes remission after laparoscopic Roux-en-Y gastric bypass.

Iacobellis G, Xu C, Campo RE, De La Cruz-Munoz NF.

Obes Surg. 2015 May;25(5):782-7. doi: 10.1007/s11695-014-1477-6.

PMID:
25361763
9.
10.

Preoperative Prediction of Type 2 Diabetes Remission After Gastric Bypass Surgery: a Comparison of DiaRem Scores and ABCD Scores.

Lee WJ, Chong K, Chen SC, Zachariah J, Ser KH, Lee YC, Chen JC.

Obes Surg. 2016 Mar 2. [Epub ahead of print]

PMID:
26932813
11.

Safety and efficacy of Roux-en-Y gastric bypass to treat type 2 diabetes mellitus in non-severely obese patients.

Boza C, Muñoz R, Salinas J, Gamboa C, Klaassen J, Escalona A, Pérez G, Ibañez L, Guzmán S.

Obes Surg. 2011 Sep;21(9):1330-6. doi: 10.1007/s11695-011-0463-5.

PMID:
21744283
12.

Roux-en-Y gastric bypass for diabetes (the Diabetes Surgery Study): 2-year outcomes of a 5-year, randomised, controlled trial.

Ikramuddin S, Billington CJ, Lee WJ, Bantle JP, Thomas AJ, Connett JE, Leslie DB, Inabnet WB 3rd, Jeffery RW, Chong K, Chuang LM, Sarr MG, Jensen MD, Vella A, Ahmed L, Belani K, Schone JL, Olofson AE, Bainbridge HA, Laqua PS, Wang Q, Korner J.

Lancet Diabetes Endocrinol. 2015 Jun;3(6):413-22. doi: 10.1016/S2213-8587(15)00089-3. Epub 2015 May 12. Erratum in: Lancet Diabetes Endocrinol. 2015 Jul;3(7):e5.

13.

Prediction of Diabetes Remission in Morbidly Obese Patients After Roux-en-Y Gastric Bypass.

Park JY, Kim YJ.

Obes Surg. 2016 Apr;26(4):749-56. doi: 10.1007/s11695-015-1823-3.

PMID:
26205218
14.

Type 2 Diabetes Remission After Gastric Bypass: What Is the Best Prediction Tool for Clinicians?

Cotillard A, Poitou C, Duchâteau-Nguyen G, Aron-Wisnewsky J, Bouillot JL, Schindler T, Clément K.

Obes Surg. 2015 Jul;25(7):1128-32. doi: 10.1007/s11695-014-1511-8.

PMID:
25387683
15.

[Efficacy of modified Roux-en-Y gastric bypass in the treatment of non-obese type 2 diabetes mellitus:one year follow-up].

Chen YF, Yang F, Yang YL, Wu N, Zheng ZG, Li XL, Yang B, Wang L, Chen Y, Lian HL, Song B, Xue YJ, Cai HW, Dou KF, Chen Y.

Zhonghua Wai Ke Za Zhi. 2012 Oct;50(10):879-82. Chinese.

PMID:
23302455
16.

Outcomes in glycemic control in the intermediate follow-up of Roux-en-Y gastric bypass: a Brazilian cohort study.

Beleigoli AM, Coelho AL, Diniz MT, Lages Savassi-Rocha A, Diniz Mde F.

Surg Obes Relat Dis. 2014 Nov-Dec;10(6):1022-7. doi: 10.1016/j.soard.2014.08.016. Epub 2014 Sep 6.

PMID:
25445150
17.

Attenuated improvements in adiponectin and fat loss characterize type 2 diabetes non-remission status after bariatric surgery.

Malin SK, Bena J, Abood B, Pothier CE, Bhatt DL, Nissen S, Brethauer SA, Schauer PR, Kirwan JP, Kashyap SR.

Diabetes Obes Metab. 2014 Dec;16(12):1230-8. doi: 10.1111/dom.12376. Epub 2014 Sep 14.

18.

Predictive factors of type 2 diabetes remission 1 year after bariatric surgery: impact of surgical techniques.

Robert M, Ferrand-Gaillard C, Disse E, Espalieu P, Simon C, Laville M, Gouillat C, Thivolet C.

Obes Surg. 2013 Jun;23(6):770-5. doi: 10.1007/s11695-013-0868-4.

PMID:
23355293
19.

Laparoscopic Roux-en-Y gastric bypass for nonobese type II diabetes mellitus in Asian patients.

Malapan K, Goel R, Tai CM, Kao YH, Chang PC, Huang CK.

Surg Obes Relat Dis. 2014 Sep-Oct;10(5):834-40. doi: 10.1016/j.soard.2014.01.018. Epub 2014 Jan 28.

PMID:
24857051
20.

Roux-en-Y gastric bypass surgery or lifestyle with intensive medical management in patients with type 2 diabetes: feasibility and 1-year results of a randomized clinical trial.

Halperin F, Ding SA, Simonson DC, Panosian J, Goebel-Fabbri A, Wewalka M, Hamdy O, Abrahamson M, Clancy K, Foster K, Lautz D, Vernon A, Goldfine AB.

JAMA Surg. 2014 Jul;149(7):716-26. doi: 10.1001/jamasurg.2014.514.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk